Oss, Netherlands

Vera De Kimpe

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Lead Pharma Holding B.v., Sanofi. Active years: 2019.

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Vera De Kimpe: Innovator in ROR Gamma Modulators

Introduction

Vera De Kimpe is a notable inventor based in Oss, Netherlands. She has made significant contributions to the field of pharmaceutical compounds, particularly in the development of ROR gamma (RORy) modulators. With a total of 3 patents, her work focuses on innovative solutions for treating autoimmune and inflammatory diseases.

Latest Patents

Vera's latest patents include compounds that act as inhibitors of RORy, which are crucial for addressing RORy mediated diseases. The compounds are described by specific formulas that include various chemical moieties, such as cyclopropyl and alkyl groups, which enhance their efficacy. These inventions represent a significant advancement in the treatment of conditions linked to RORy.

Career Highlights

Throughout her career, Vera has worked with prominent companies in the pharmaceutical industry, including Lead Pharma Holding B.V. and Sanofi. Her expertise in the development of RORy modulators has positioned her as a key player in the field of medicinal chemistry.

Collaborations

Vera has collaborated with esteemed colleagues such as Joseph Maria Gerardus Barbara Cals and Sander Bernardus Nabuurs. These partnerships have further enriched her research and development efforts in the pharmaceutical domain.

Conclusion

Vera De Kimpe's innovative work in ROR gamma modulators showcases her dedication to advancing medical treatments. Her contributions are vital in the ongoing fight against autoimmune and inflammatory diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…